arbekacin has been researched along with gentamicin in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.81) | 18.7374 |
1990's | 6 (22.22) | 18.2507 |
2000's | 12 (44.44) | 29.6817 |
2010's | 5 (18.52) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fillastre, JP; Morin, JP; Olier, B; Thomas, N | 1 |
Price, KE | 1 |
Coude du Foresto, B; Courtieu, AL; Derriennic, M; Reynaud, AE | 1 |
Bouanchaud, DH; Rolin, O | 1 |
Ida, T; Inoue, M; Nonoyama, M; Okamoto, R | 1 |
Fujita, K; Nagamachi, Y; Okubo, T; Suzuki, T | 1 |
Goto, S; Sugano, T; Takada, T; Takase, Y; Tsuji, A; Yamaguchi, K; Yoshida, T | 1 |
Higurashi, Y; Nakahara, K; Okuzumi, K; Yoneyama, A | 1 |
Chow, JW; Chow, L; Kariyama, R; Kumon, H; Tabata, M; Takata, T; Zervos, MJ | 1 |
Endo, K | 1 |
Chow, JW; Kariyama, R; Kumon, H; You, I; Zervos, MJ | 1 |
Akins, RL; Rybak, MJ | 1 |
Chow, JW; Donabedian, SM; Kak, V; Kariyama, R; Kumon, H; Zervos, MJ | 1 |
Chow, JW; Kak, V; Kariyama, R; Kumon, H; You, I; Zervos, MJ | 1 |
Hashimoto, Y; Kato, M; Liu, M | 1 |
Higashi, K; Itoman, M; Miyabe, M; Naruse, K; Takahira, N; Uchiyama, K | 1 |
Matsuzaki, T; Suzuki, K; Tanikawa, K | 1 |
Choi, JH; Choi, SM; Chun, HS; Kang, MW; Lee, DG; Shin, WS; Yim, DS; Yoo, JH | 1 |
Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
Udou, T | 1 |
Akama, H; Barada, K; Hanaki, H; Ikeda, S; Inamatsu, T; Nakae, T; Sunakawa, K; Yamaguchi, Y | 1 |
Fujii, K; Nagai, J; Sawada, T; Takano, M; Yumoto, R | 1 |
Araoka, H; Baba, M; Ishii, Y; Mitsuda, T; Mori, S; Moriya, K; Nakamori, Y; Oguri, T; Ohmagari, N; Oishi, T; Okuzumi, K; Tateda, K; Yamaguchi, K; Yoneyama, A | 1 |
Kirikae, T; Miyoshi-Akiyama, T; Shimada, K; Shimojima, M; Tada, T | 1 |
Fudaba, Y; Hattori, M; Hirakawa, H; Hisatsune, J; Kato, F; Kayama, S; Oshima, K; Sugai, M; Yamaguchi, T | 1 |
Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
Takeshima, Y | 1 |
2 review(s) available for arbekacin and gentamicin
Article | Year |
---|---|
The potential for discovery and development of improved aminoglycosides.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Kanamycin; Lethal Dose 50; Mice; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1986 |
[Genetic Diagnosis and Molecular Therapies for Duchenne Muscular Dystrophy].
Topics: Animals; Codon, Nonsense; Dibekacin; Dystrophin; Exons; Gentamicins; Humans; Mice; Molecular Targeted Therapy; Muscular Dystrophy, Duchenne; Oligonucleotides, Antisense; Pathology, Molecular; Prostaglandin D2 | 2015 |
25 other study(ies) available for arbekacin and gentamicin
Article | Year |
---|---|
[Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Female; Gentamicins; Kanamycin; Kidney Cortex; Kidney Diseases; Netilmicin; Rats; Rats, Inbred Strains | 1988 |
[Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Topics: Acinetobacter; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 1988 |
Protective activity of habekacin and four other aminoglycosides in mouse septicaemia caused by Enterobacteriaceae.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Enterobacteriaceae Infections; Female; Gentamicins; Kanamycin; Male; Mice; Microbial Sensitivity Tests; Sepsis; Tobramycin | 1986 |
Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Coagulase; Dibekacin; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Gentamicins; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1994 |
[Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Genes, Bacterial; Gentamicins; Methicillin Resistance; Mutation; Phosphotransferases; Staphylococcus aureus | 1994 |
[Evaluation of bactericidal activity of arbekacin in mixed culture with MRSA and Pseudomonas aeruginosa using an in vitro pharmacokinetic simulation system].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Computer Simulation; Dibekacin; Gentamicins; Male; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
[The in vitro antibacterial activity of cefozopran against clinically isolated bacteria].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefozopran; Cephalosporins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Vancomycin | 1997 |
In-vitro activity of the combination of ampicillin and arbekacin against high-level gentamicin-resistant enterococci.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests | 1998 |
[Neuromuscular blocking properties of arbekacin, astromicin, isepamicin and netilmicin in the rabbit].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; Netilmicin; Neuromuscular Blocking Agents; Rabbits; Tubocurarine | 1999 |
In-vitro activity of arbekacin alone and in combination with vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Dibekacin; DNA, Bacterial; Drug Interactions; Drug Resistance, Multiple; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sensitivity and Specificity; Staphylococcus aureus; Vancomycin | 2000 |
In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Dibekacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2000 |
Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resistance.
Topics: Aminoglycosides; Ampicillin; Animals; Anti-Bacterial Agents; Dibekacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Rabbits; Treatment Outcome | 2000 |
In-vitro synergistic activity of the combination of ampicillin and arbekacin against vancomycin-and high-level gentamicin-resistant Enterococcus faecium with the aph(2")-Id gene.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Dibekacin; DNA, Bacterial; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Streptomycin; Vancomycin | 2000 |
Neuromuscular blocking effects of the aminoglycoside antibiotics arbekacin, astromicin, isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Diaphragm; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; In Vitro Techniques; Male; Muscle Contraction; Muscle, Skeletal; Netilmicin; Neuromuscular Junction; Rabbits | 2001 |
Treatment outcome of two-stage revision total hip arthroplasty for infected hip arthroplasty using antibiotic-impregnated cement spacer.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bone Cements; Dibekacin; Female; Gentamicins; Hip Prosthesis; Humans; Male; Middle Aged; Prosthesis-Related Infections; Reoperation; Treatment Outcome | 2003 |
Pharmacokinetics and dosing of arbekacin in preterm and term newborn infants.
Topics: Aminoglycosides; Anti-Bacterial Agents; Dibekacin; Gentamicins; Gestational Age; Humans; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature | 2003 |
Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Topics: Aminoglycosides; Anti-Bacterial Agents; Area Under Curve; Blood Coagulation; Colony Count, Microbial; Dibekacin; Drug Therapy, Combination; Endocarditis, Bacterial; Fibrin; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Models, Biological; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
Topics: Amikacin; Aminoglycosides; Antitubercular Agents; Colony Count, Microbial; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Kanamycin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Mycobacterium tuberculosis; Nocardia asteroides; Nontuberculous Mycobacteria; Prevalence; Streptomycin; Tobramycin | 2006 |
Trends in the gentamicin and arbekacin susceptibility of methicillin-resistant Staphylococcus aureus and the genes encoding aminoglycoside-modifying enzymes.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Dibekacin; Drug Resistance, Multiple, Bacterial; Gentamicins; Hospitals, Convalescent; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Tokyo | 2007 |
Effect of PEGylation of N-WASP181-200 on the inhibitory potency for renal aminoglycoside accumulation.
Topics: Animals; Anti-Bacterial Agents; Dibekacin; Gentamicins; Kidney; Male; Mice; Mice, Inbred Strains; Peptide Fragments; Polyethylene Glycols; Protein Conformation; Rats; Rats, Wistar; Wiskott-Aldrich Syndrome Protein, Neuronal | 2009 |
In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in Japan.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Dibekacin; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Gentamicins; Humans; Japan; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Statistics, Nonparametric | 2012 |
novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa.
Topics: Acetylation; Acetyltransferases; Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Chromatography, Thin Layer; Dibekacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Gentamicins; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity | 2013 |
Emergence of Staphylococcus aureus carrying multiple drug resistance genes on a plasmid encoding exfoliative toxin B.
Topics: Anti-Bacterial Agents; Base Sequence; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Exfoliatins; Gentamicins; Humans; Impetigo; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Retrospective Studies; Staphylococcal Scalded Skin Syndrome; Staphylococcus aureus | 2013 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |